Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2017

01.02.2017 | Brief Report

Metabolic syndrome and incidence of breast cancer in middle-aged Korean women: a nationwide cohort study

verfasst von: Jung Ah Lee, Jung Eun Yoo, Hye Soon Park

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the risk of breast cancer in middle-aged women with metabolic syndrome using the National Health Insurance Service-National Sample Cohort (NHIS-NSC).

Methods

We analyzed 23,820 women aged 50–64 years who participated in the NHIS-NCS in 2008 and 2009. We excluded subjects with any previous history of cancer or with inadequate information regarding metabolic syndrome. Participated subjects underwent anthropometric measurements and provided fasting blood samples for the assessment of glucose and lipid profiles, and answered a lifestyle questionnaire. Cox regression analysis was performed to evaluate relative risks (RRs) and 95% confidence intervals (CIs) for the association between metabolic syndrome and breast cancer.

Results

During the 5-year follow-up, 131 subjects were newly diagnosed with breast cancer (incidence, 10.86 per 10,000 person years). After adjusting for age and body mass index, the RR for incident breast cancer in participants with metabolic syndrome versus those without it was 1.47 (95% CI 1.01–2.13). For those individuals of metabolic syndrome, hyperglycemia was most primarily related with the incidence of breast cancer (RR 1.44, 95% CI 1.02–2.04).

Conclusions

Among the study individuals who were middle-aged Korean women, metabolic syndrome is highly related with the risk of breast cancer. Therefore, it needs to be managed or prevented to reduce the incidence of breast cancer.
Literatur
1.
Zurück zum Zitat Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC (2009) Harmonizing the metabolic syndrome a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120(16):1640–1645CrossRefPubMed Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC (2009) Harmonizing the metabolic syndrome a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120(16):1640–1645CrossRefPubMed
2.
Zurück zum Zitat Ballantyne C, Hoogeveen R, McNeill A, Heiss G, Schmidt MI, Duncan B, Pankow J (2008) Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes 32:S21–S24CrossRef Ballantyne C, Hoogeveen R, McNeill A, Heiss G, Schmidt MI, Duncan B, Pankow J (2008) Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes 32:S21–S24CrossRef
3.
Zurück zum Zitat Malik S, Wong ND, Franklin SS, Kamath TV, Gilbert J, Pio JR, Williams GR (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110(10):1245–1250CrossRefPubMed Malik S, Wong ND, Franklin SS, Kamath TV, Gilbert J, Pio JR, Williams GR (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110(10):1245–1250CrossRefPubMed
4.
Zurück zum Zitat Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D (2012) Metabolic syndrome and risk of cancer a systematic review and meta-analysis. Diabetes Care 35(11):2402–2411CrossRefPubMedPubMedCentral Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D (2012) Metabolic syndrome and risk of cancer a systematic review and meta-analysis. Diabetes Care 35(11):2402–2411CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Lee J, Cho S-I, Park H (2010) Metabolic syndrome and cancer-related mortality among Korean men and women. Ann Oncol 21(3):640–645CrossRefPubMed Lee J, Cho S-I, Park H (2010) Metabolic syndrome and cancer-related mortality among Korean men and women. Ann Oncol 21(3):640–645CrossRefPubMed
6.
Zurück zum Zitat Lee W-Y, Park J-S, Noh S-Y, Rhee E-J, Kim S-W, Zimmet PZ (2004) Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 65(2):143–149CrossRefPubMed Lee W-Y, Park J-S, Noh S-Y, Rhee E-J, Kim S-W, Zimmet PZ (2004) Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 65(2):143–149CrossRefPubMed
7.
Zurück zum Zitat Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359CrossRefPubMed Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359CrossRefPubMed
8.
Zurück zum Zitat Carr MC (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88(6):2404–2411CrossRefPubMed Carr MC (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88(6):2404–2411CrossRefPubMed
9.
Zurück zum Zitat Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V (2010) Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case–control study. Nutr Metab Cardiovasc Dis 20(1):41–48CrossRefPubMed Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V (2010) Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case–control study. Nutr Metab Cardiovasc Dis 20(1):41–48CrossRefPubMed
10.
Zurück zum Zitat Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML (2009) A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev 18(7):2046–2053CrossRef Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML (2009) A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev 18(7):2046–2053CrossRef
11.
Zurück zum Zitat Lim U, Ernst T, Buchthal S, Latch M, Albright CL, Wilkens LR, Kolonel L, Murphy S, Chang L, Novotny R (2011) Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr Diabetes 1(5):e6CrossRefPubMedPubMedCentral Lim U, Ernst T, Buchthal S, Latch M, Albright CL, Wilkens LR, Kolonel L, Murphy S, Chang L, Novotny R (2011) Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr Diabetes 1(5):e6CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Lee J, Lee JS, Park S-H, Shin SA, Kim K (2016) Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. doi:10.1093/ije/dyv319 Lee J, Lee JS, Park S-H, Shin SA, Kim K (2016) Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. doi:10.​1093/​ije/​dyv319
13.
Zurück zum Zitat Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 23(5):469–480CrossRefPubMed Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 23(5):469–480CrossRefPubMed
14.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefPubMed
15.
Zurück zum Zitat Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjønneland A, Overvad K, Jeppesen M, Clavel-Chapelon F (2006) Serum C-peptide levels and breast cancer risk: results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 119(3):659–667CrossRefPubMed Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjønneland A, Overvad K, Jeppesen M, Clavel-Chapelon F (2006) Serum C-peptide levels and breast cancer risk: results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 119(3):659–667CrossRefPubMed
16.
Zurück zum Zitat Goodwin PJ, Ennis M, Bahl M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N (2009) High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat 114(3):517–525CrossRefPubMed Goodwin PJ, Ennis M, Bahl M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N (2009) High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat 114(3):517–525CrossRefPubMed
17.
Zurück zum Zitat Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 1229(1):45–52CrossRefPubMed Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 1229(1):45–52CrossRefPubMed
18.
Zurück zum Zitat Shanik MH, Xu Y, Škrha J, Dankner R, Zick Y, Roth J (2008) Insulin Resistance and Hyperinsulinemia Is hyperinsulinemia the cart or the horse? Diabetes Care 31(Supplement 2):S262–S268CrossRefPubMed Shanik MH, Xu Y, Škrha J, Dankner R, Zick Y, Roth J (2008) Insulin Resistance and Hyperinsulinemia Is hyperinsulinemia the cart or the horse? Diabetes Care 31(Supplement 2):S262–S268CrossRefPubMed
19.
Zurück zum Zitat Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin–IGF axis. Trends Endocrinol Metab 17(8):328–336CrossRefPubMed Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin–IGF axis. Trends Endocrinol Metab 17(8):328–336CrossRefPubMed
20.
Zurück zum Zitat Hormones TE, Group BCC (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11(6):530–542CrossRef Hormones TE, Group BCC (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11(6):530–542CrossRef
21.
Zurück zum Zitat Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, Grimaldi M, De Marco MR, Cavalcanti E, D’Aiuto M, Fucito A (2010) Metabolic syndrome affects breast cancer risk in postmenopausal women: national Cancer Institute of Naples experience. Cancer Biol Ther 10(12):1240–1243CrossRefPubMed Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, Grimaldi M, De Marco MR, Cavalcanti E, D’Aiuto M, Fucito A (2010) Metabolic syndrome affects breast cancer risk in postmenopausal women: national Cancer Institute of Naples experience. Cancer Biol Ther 10(12):1240–1243CrossRefPubMed
22.
Zurück zum Zitat Dowsett M, Folkerd E (2015) Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis. Breast Cancer Res Treat 149(1):1–4CrossRefPubMed Dowsett M, Folkerd E (2015) Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis. Breast Cancer Res Treat 149(1):1–4CrossRefPubMed
23.
Zurück zum Zitat Group EHBCC (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95(16):1218–1226CrossRef Group EHBCC (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95(16):1218–1226CrossRef
Metadaten
Titel
Metabolic syndrome and incidence of breast cancer in middle-aged Korean women: a nationwide cohort study
verfasst von
Jung Ah Lee
Jung Eun Yoo
Hye Soon Park
Publikationsdatum
01.02.2017
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2017
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4131-x

Weitere Artikel der Ausgabe 2/2017

Breast Cancer Research and Treatment 2/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.